The drug industry spends billions annually on brain diseases. But, 94% of neurological drugs that appear safe and effective in animal models fail in human trials. One explanation is the complex variation between the brains of animals and humans. In an effort to improve drug success, we propose a new way to reveal the similarity and difference between species using brain maps. Once developed, this analysis will help researchers predict drug success potential with greater accuracy.